Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Brenner Malcolm
Director at Kalaris Therapeutics. Filing since 16 Feb 2021.
CIK 0001818068
Company
Date
Role
Action
Shares
Amount
Of holding
KLRS
Kalaris Therapeutics, Inc.
5 Mar 2021
Director
Sold, plan not stated
48,091
$1.50M
5.5%
KLRS
Kalaris Therapeutics, Inc.
4 Mar 2021
Director
Sold, plan not stated
49,598
$1.78M
5.4%
KLRS
Kalaris Therapeutics, Inc.
3 Mar 2021
Director
Sold, plan not stated
17,915
$679.95K
1.9%
KLRS
Kalaris Therapeutics, Inc.
2 Mar 2021
Director
Sold, plan not stated
12,658
$482.39K
1.3%
KLRS
Kalaris Therapeutics, Inc.
1 Mar 2021
Director
Sold, plan not stated
21,694
$838.23K
2.2%
KLRS
Kalaris Therapeutics, Inc.
23 Feb 2021
Director
Sold, plan not stated
8,489
$335.04K
0.9%
KLRS
Kalaris Therapeutics, Inc.
22 Feb 2021
Director
Sold, plan not stated
11,423
$486.25K
1.2%
KLRS
Kalaris Therapeutics, Inc.
19 Feb 2021
Director
Sold, plan not stated
11,990
$500.94K
1.2%
KLRS
Kalaris Therapeutics, Inc.
18 Feb 2021
Director
Sold, plan not stated
6,757
$275.37K
0.7%
KLRS
Kalaris Therapeutics, Inc.
17 Feb 2021
Director
Sold, plan not stated
5,165
$208.93K
0.5%
KLRS
Kalaris Therapeutics, Inc.
16 Feb 2021
Director
Sold, plan not stated
6,220
$260.33K
0.6%
11 decisions on file.
